NLS Pharmaceutics Ltd (NAS:NLSP)
$ 4.9 0.0246 (0.5%) Market Cap: 5.74 Mil Enterprise Value: 6.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

NLS Pharmaceutics AG at Wake Up Narcolepsy International Narcolepsy Webinar Transcript

Jan 20, 2022 / 05:45 PM GMT
Release Date Price: $40.8 (-4.67%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NLSP.OQ - NLS Pharmaceutics AG
NLS Pharmaceutics AG at Wake Up Narcolepsy International Narcolepsy Webinar
Jan 20, 2022 / 05:45PM GMT

=====================
Conference Call Participants
=====================
* Helene Emsellem
The Centre for Sleep & Wake Disorders - Director

=====================
Presentation
--------------------------------------------------------------------------------
Helene Emsellem, The Centre for Sleep & Wake Disorders - Director [1]
--------------------------------------------------------------------------------
Okay. I'm here today to talk to you about narcolepsy and to focus on current and emerging therapies. Next slide.

These are my disclaimers and disclosures. I am very actively involved in clinical research trials. And have been involved and I'm actively involved in many of the trials of compounds that will get discussed. And as Monica mentioned, this talk is sponsored by NLS. Thank you.

The goals today are to do an overview of narcolepsy, talk a little
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot